Evidence map›Paper›PMID 37193499›Full record

ReviewJournal of parasitic diseases : official organ of the Indian Society for Parasitology2023

Myxozoan fish diseases: possible treatment and zoonoses.

Husne Banu, R Bharathi Rathinam

Open access · greenAbstract readReview
In one paragraph

Review in Journal of parasitic diseases : official organ of the Indian Society for Parasitology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Husne BanuICAR-Central Institute of Fisheries Education, Salt Lake City, Kolkata, 700091 India.ORCID 0000-0002-1158-3892
R Bharathi RathinamICAR-Central Institute of Fisheries Education, Mumbai, 400061 India.
Central Institute for Women in Agriculture · INCentral Institute of Fisheries Education · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myxozoan parasites pose huge threat to wild and cultured fishes and reported to cause heavy mortality, retarded growth and post-harvest quality degradation. It is one of the highly divergent groups of parasites which infects skin, gill, muscle, cartilage and internal organs of host fish and the severity of pathology varies depending on the water temperature, species of fish, site of tissue infection and immune resistance of the individual host. Most infections are difficult to treat, as they can easily evade host cellular and humoral defence mechanisms by proliferating or migrating through immune compromised sites of the host and forming large plasmodia encapsulated by the host cellular elements. This spore-forming parasite is harmless to humans but often detected in faecal samples of immunosuppressed humans. The incidences are mostly associated with the consumption of infected fish having a high concentration of spores which causes diarrhea and stomach pain. Currently, there are no immunostimulants or vaccines available for controlling these parasites, however, fumagillin is the drug of choice in fish for controlling this parasitic infection. Excessive usage of fumagillin causes tissue damage and retarded growth in fish, hence feed incorporation of this antibiotic in proper dose is essential for effective treatment. In this review detailed information on the diseases caused by myxozoan parasites in fishes and their zoonotic potential is discussed.

Indexed as

ChemotherapyMyxozoan parasitesZoonoses

Identifiers

PMID37193499
PMCPMC10182238
OpenAlexW4360994699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.